Long-term (+52 weeks) randomized controlled trial of anti-depressants shows that they're safe and effective
One-OffGezondheid en geneeskunde3jManifold MarketsGeen KYCGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdHuidige gemeenschapsvoorspellingJa 68.8%
Voorspellers
7
Vraagtype
binary
Methodologie
Play-money forecasting platform
Brontype
Voorspelling
Marktdata
Bijgewerkt 21 uur geleden
Verouderd6 mrt 25, 19:37 UTC14 mrt 30, 10:59 UTC
Trends
Regels
Randomized placebo-controlled studies of antidepressants are under 52 weeks, yet the median use of antidepressants is 5 years.
- This market predicts whether the next eligible trial of antidepressants shows that they are safe and effective over 52 weeks duration
- Definitions:
- eligible trial - placebo-controlled randomized controlled trial over 52 weeks that measures both efficacy and safety
- effective - beats placebo control
- safe - risks and side effects are not found to be worse than currently known
